论文部分内容阅读
目的 :探究奥曲肽、垂体后叶素治疗肝硬化上消化道出血的疗效。方法 :基于本院自2014年12月-2015年12月期间收治的50例肝硬化上消化道出血患者的临床资料,按照临床治疗方式的不同,随机的将这50例患者分为对照组(单纯的进行奥曲肽治疗)和观察组(行奥曲肽+垂体后叶素治疗),两组各25例,观察比较两组患者的临床疗效及并发症发生情况。结果 :观察组25例患者的临床疗效(治疗总有效率为80%)明显的优于对照组25例患者的临床疗效(治疗总有效率为56%)(P<0.05),具有统计学意义;观察组25例患者的并发症发生率32%明显的低于对照组25例患者的并发症发生率60%(P<0.05),具有统计学意义。结论 :对肝硬化上消化道出血患者进行奥曲肽+垂体后叶素治疗,能够有效的消解患者的不良反应,全面的提升临床疗效,改善患者的生活质量,值得推荐。
Objective: To investigate the curative effect of octreotide and pituitrin on cirrhosis with upper gastrointestinal hemorrhage. Methods: Based on the clinical data of 50 patients with upper gastrointestinal hemorrhage who were treated in our hospital from December 2014 to December 2015, 50 patients were randomly divided into control group (according to clinical treatment) Pure octreotide treatment) and observation group (octreotide + pituitrin treatment), two groups of 25 cases each. The clinical efficacy and complications of the two groups were observed and compared. Results: The clinical efficacy (total effective rate was 80%) in 25 patients in the observation group was significantly better than that in the 25 patients in the control group (total effective rate was 56%) (P <0.05), with statistical significance ; The complication rate of 25 patients in the observation group was significantly lower than 32% of the 25 patients in the control group (P <0.05), which was statistically significant. Conclusion: The treatment of cirrhosis patients with upper gastrointestinal hemorrhage octreotide pituitrin treatment can effectively eliminate the adverse reactions in patients with comprehensive clinical efficacy and improve patient quality of life, it is recommended.